[144] TD SYNNEX Corporation SEC Filing
Rhea-AI Filing Summary
TD SYNNEX (SNX) Form 144 notice reports a proposed sale of 9,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,331,910 and approximately 82,467,079 shares outstanding, indicating the planned sale represents a small fraction of outstanding stock. The filer acquired most shares as RSA and RSU awards in January 2023. The filing also discloses recent sales over the past three months by the named individual and a related family trust under 10b5-1 plans totaling 29,250 shares for gross proceeds reported.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small planned sale relative to float; recent 10b5-1 activity suggests orderly, preplanned dispositions rather than ad hoc insider sales.
This Form 144 shows a proposed disposition of 9,000 shares valued at $1.33M against ~82.47M shares outstanding, a de minimis percentage of the share count. The acquisition history lists RSA and RSU grants from January 2023, so the shares originate from standard equity compensation. Recent executed sales include 3,000 and 3,000-share 10b5-1 transactions plus a 14,250-share sale, generating reported proceeds; these are disclosed and consistent with planned sales mechanics rather than sudden market exits. Overall investor impact appears neutral given scale.
TL;DR: Filing documents compliance with Rule 144 and notes 10b5-1 plan usage, demonstrating procedural adherence by the filer.
The notice provides required disclosure elements including acquisition dates (01/20/2023 and 01/24/2023) and the nature of acquisitions (RSA and RSU). Broker information is specified for the proposed sale. The remarks reiterate the filers representation about lacking undisclosed material information and reference reliance on 10b5-1 instructions where applicable. From a governance perspective, the filing meets procedural expectations and provides transparency on recent share dispositions.